Source:http://linkedlifedata.com/resource/pubmed/id/12738358
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2003-5-9
|
pubmed:abstractText |
Human immunodeficiency virus (HIV)-specific T cells play a critical role in anti-virus immunity. Therefore, during the clinical development of immune-based therapies, it is important to perform a diagnostic test that rapidly quantifies and characterizes cellular immune responses. For detection of functional HIV-specific CD8(+) cytotoxic T cells (CTL), we used a rapid vaccinia assay that employs recombinant vaccinia virus-infected peripheral blood mononuclear cells (PBMC). This assay was compared with the traditional 51Cr-release CTL assay and with the peptide pool-based enzyme-linked immunospot assay (ELISPOT). We demonstrated a close correlation between these assays by using identical antigens in parallel assays. However, the vaccinia assay was the least expensive and time- and labor-consuming test. Regarding sensitivity, the vaccinia assay was similar to both the peptide pool-based ELISPOT and CTL assays. We showed that human histocompatibility leukocyte antigen (HLA)-Dr(+) cells are responsible for presenting recombinant vaccinia antigens to T cells. The recombinant vaccinia-based assay is a rapid, sensitive and quantitative test and is thus suitable for the detection of functional antigen-specific CD8(+) CTL in large-scale clinical studies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-1759
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
276
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-57
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12738358-Antigen-Presenting Cells,
pubmed-meshheading:12738358-B-Lymphocytes,
pubmed-meshheading:12738358-Cell Line,
pubmed-meshheading:12738358-Coculture Techniques,
pubmed-meshheading:12738358-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:12738358-DNA, Recombinant,
pubmed-meshheading:12738358-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12738358-Flow Cytometry,
pubmed-meshheading:12738358-HIV Antigens,
pubmed-meshheading:12738358-HIV-1,
pubmed-meshheading:12738358-Interferon-gamma,
pubmed-meshheading:12738358-Leukocytes, Mononuclear,
pubmed-meshheading:12738358-Peptides,
pubmed-meshheading:12738358-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:12738358-Time Factors,
pubmed-meshheading:12738358-Vaccinia
|
pubmed:year |
2003
|
pubmed:articleTitle |
Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes.
|
pubmed:affiliation |
Research Institute for Genetic and Human Therapy (RIGHT), Washington, DC, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Evaluation Studies
|